Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

12
Number of overlapping holdings
50.0%
% of PPH's 27 holdings also in XPH
32.4%
% of XPH's 40 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PPH |
Weight in XPH |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 6.1% | 5.6% | 5.6% | |
ZOETIS INC | 4.6% | 4.8% | 4.6% | |
VIATRIS, INC. | 4.2% | 4.5% | 4.2% | |
MERCK & CO. INC. | 4.6% | 4.2% | 4.2% | |
JOHNSON & JOHNSON | 4.7% | 4.0% | 4.0% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to XPH
TEVA PHARMACEUTICAL-SP ADR | 5.8% | |
NOVO-NORDISK A/S-SPONS ADR | 5.6% | |
ABBVIE INC | 5.2% | |
SANOFI-AVENTIS-ADR | 5.0% | |
NOVARTIS AG-ADR | 4.9% | |
MCKESSON CORP | 4.6% | |
GLAXOSMITHKLINE PLC-SPON ADR | 4.6% | |
ASTRAZENECA PLC-SPONS ADR | 4.3% | |
AMERISOURCEBERGEN CORP | 4.3% | |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.3% |
PPH Underweight Relative to XPH
REATA PHARMACEUTICALS, INC. CLASS A | -7.9% | |
AXSOME THERAPEUTICS, INC. | -4.4% | |
ELANCO ANIMAL HEALTH, INC. | -3.8% | |
ROYALTY PHARMA PLC CLASS A | -3.7% | |
INTRA-CELLULAR THERAPIES INC | -3.6% | |
VENTYX BIOSCIENCES, INC. | -3.0% | |
CATALENT INC | -2.7% | |
HARMONY BIOSCIENCES HOLDINGS, INC. | -2.3% | |
CORCEPT THERAPEUTICS INC | -2.2% | |
CYMABAY THERAPEUTICS, INC. | -2.1% |